Can Big Pharma's Sheri McCoy Give Avon a Makeover?
Within the health-care industry, Sheri McCoy is a star. But can a woman who narrowly missed becoming chief executive officer at Johnson & Johnson in February thrive instead at the helm of Avon Products?
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.